EDGEWISE THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.13 USD | -2.11% |
|
+0.12% | +56.58% |
| 10/05 | Wedbush Raises Edgewise Therapeutics' PT to $31 From $26, Keeps Outperform Rating | MT |
| 09/05 | Edgewise Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Biotechnology & Medical Research
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 159.99Cr | - | - | - | - | - | |
| 5.46TCr | - | |||||
| 3.99TCr | ||||||
| 3.88TCr | ||||||
| 2.69TCr | ||||||
| 2.62TCr |
